Literature DB >> 16757985

Management of borderline personality disorder: a review of psychotherapeutic approaches.

Michael H Stone1.   

Abstract

There are currently three major psychotherapeutic approaches to the management of borderline personality disorder (BPD): the psychodynamic, the cognitive-behavioral, and the supportive. There are special varieties within each: e.g., transference-focused psychotherapy (psychodynamic) or dialectic behavioral therapy (cognitive-behavioral). Though differing in basic conceptions and in methodology, all approaches aim at the amelioration of both the symptom-aspects that dominate the clinical picture at the outset, and the personality difficulties that remain apparent after the symptoms have been alleviated. The term "management" implies a focus on the more serious aspects of the borderline picture. These can be pictured hierarchically as to their level of seriousness, and there is universal agreement about the nature of this hierarchy. Therapists must pay attention first to suicidal and self-mutilative behaviors. Next, one deals with any threats to interrupt therapy prematurely. Third in order of seriousness: non-suicidal symptoms such as (mild to moderate) depression, substance abuse, panic and other anxiety manifestations, or dissociation. Psychopharmacological treatment will often be used adjunctively to help control any target symptoms, which usually fall into such categories as cognitive-perceptual, affect dysregulation, or impulsive/ behavioral dyscontrol. Therapists must then be alert to any signs of withholding, dishonesty, or antisocial tendencies, since these have an adverse effect on prognosis. When all these disruptive influences are (to the extent possible) dealt with, therapists will next take up milder symptoms such as social anxiety or lability of mood. Throughout this initial process, the personality-disorder attributes of BPD will become more apparent, and will usually emerge with greater clarity, once the serious symptoms have been dealt with. The management issues will gradually be supplanted with the overlapping and enduring personality issues: inappropriate anger, abrasiveness, manipulativeness, demandingness, jealousy, "all-or-none" thinking and the extreme attitudes (idealization/devaluation) that accompany such thinking, masochistic traits, etc. Under ideal circumstances, the borderline patient will have "graduated" toward a higher level of function, where (acute) management issues have been adequately dealt with or have receded into the background. Psychotherapy, individual and group, becomes the dominant intervention, with such goals as psychic integration, skills training, and the fostering of long-range ambitions relating to friendships, partner choice, and work.

Entities:  

Year:  2006        PMID: 16757985      PMCID: PMC1472266     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  14 in total

1.  Supportive psychotherapy for borderline patients: a psychoanalytic research perspective.

Authors:  Ann Halsell Appelbaum; Kenneth N Levy
Journal:  Am J Psychoanal       Date:  2002-06

2.  Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.

Authors:  Mary C Zanarini; Frances R Frankenburg; John Hennen; D Bradford Reich; Kenneth R Silk
Journal:  J Pers Disord       Date:  2005-02

3.  Long-term follow-up of borderline patients in a general hospital.

Authors:  J Paris; R Brown; D Nowlis
Journal:  Compr Psychiatry       Date:  1987 Nov-Dec       Impact factor: 3.735

Review 4.  Borderline personality organization.

Authors:  O Kernberg
Journal:  J Am Psychoanal Assoc       Date:  1967-07

5.  Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm.

Authors:  H S Akiskal
Journal:  Psychiatr Clin North Am       Date:  1981-04

6.  Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.

Authors:  M C Zanarini; F R Frankenburg; A A Vujanovic; J Hennen; D B Reich; K R Silk
Journal:  Acta Psychiatr Scand       Date:  2004-12       Impact factor: 6.392

7.  The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change.

Authors:  J F Clarkin; P A Foelsch; K N Levy; J W Hull; J C Delaney; O F Kernberg
Journal:  J Pers Disord       Date:  2001-12

8.  Comorbidity of axis I and axis II disorders.

Authors:  J M Oldham; A E Skodol; H D Kellman; S E Hyler; N Doidge; L Rosnick; P E Gallaher
Journal:  Am J Psychiatry       Date:  1995-04       Impact factor: 18.112

9.  The Chestnut Lodge follow-up study. III. Long-term outcome of borderline personalities.

Authors:  T H McGlashan
Journal:  Arch Gen Psychiatry       Date:  1986-01

Review 10.  A current view of the interface between borderline personality disorder and depression.

Authors:  J G Gunderson; K A Phillips
Journal:  Am J Psychiatry       Date:  1991-08       Impact factor: 18.112

View more
  5 in total

1.  Regression: Diagnosis, Evaluation, and Management.

Authors:  Hermioni N Lokko; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2015-05-14

2.  The mental health clinic: a new model.

Authors:  Giovanni A Fava; Seugn K Park; Steven L Dubovsky
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 3.  Interpersonal dysfunction in borderline personality: a decision neuroscience perspective.

Authors:  Michael N Hallquist; Nathan T Hall; Alison M Schreiber; Alexandre Y Dombrovski
Journal:  Curr Opin Psychol       Date:  2017-09-23

4.  Experiences of care by Australians with a diagnosis of borderline personality disorder.

Authors:  S Lawn; J McMahon
Journal:  J Psychiatr Ment Health Nurs       Date:  2015-06-30       Impact factor: 2.952

5.  Successful interventions on an organisational level to reduce violence and coercive interventions in in-patients with adjustment disorders and personality disorders.

Authors:  Tilman Steinert; Frank Eisele; Ulla Goeser; Stefan Tschoeke; Carmen Uhlmann; Peter Schmid
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.